STAGE

Stage I
  Localized primary melonoma                                                                                         89-94 percent
Stage II
  Localized recurrence within or adjacent to the scar                                                       74-77 percent
Stage III
  Regional metastases
  IIIA In-transit metastases                                                                                              70-81 percent
  IIIB Positive regional lymph nodes                                                                               48-54 percent
  IIIAB In-transit metastases with regional nodes                                                           30-45 percent
Stage IV
  Systemic metastases,  positive iliac lymph nodes                                                         20-25 percent